{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:56:51Z","timestamp":1792454211663,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajp.2026.105012","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:20:48Z","timestamp":1778761248000},"page":"105012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Changing your perspective on fatal outcomes in clozapine-treated patients. They do not die of agranulocytosis"],"prefix":"10.1016","volume":"120","author":[{"given":"Jose","family":"de Leon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio J.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"De las Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2026.105012_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.ajp.2026.105012_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5455\/bcp.20141223052008","article-title":"Clozaphobia: fear of prescribers of clozapine for treatment of schizophrenia","volume":"24","author":"Cetin","year":"2014","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14740338.2024.2399094","article-title":"Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature","volume":"24","author":"De las Cuevas","year":"2025","journal-title":"Exp. Opin. Drug Saf."},{"key":"10.1016\/j.ajp.2026.105012_bib4","first-page":"165","article-title":"Adverse drug reactions and their fatal outcomes in clozapine-treated patients in VigiBase: comparing the top four reporting countries (US, UK Canada and Australia)","volume":"268","author":"De las Cuevas","year":"2024","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.ajp.2026.105012_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/JCP.0000000000002088","article-title":"Fatal outcomes in use of clozapine: a VigiBase study of 6402 women and 11,222 men","volume":"45","author":"De las Cuevas","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00787-024-02623-3","article-title":"Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data","volume":"34","author":"De Las Cuevas","year":"2025","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ajp.2026.105012_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/JCP.0000000000001990","article-title":"Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Par II","volume":"45","author":"de Leon","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/JCP.0000000000001987","article-title":"Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part I: a review of the pharmacokinetic literature and proposed changes","volume":"45","author":"de Leon","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/JCP.0000000000002111","article-title":"Clozapine and suicide in VigiBase: most important fatal outcome in young males and differences between attempted and completed suicide","volume":"46","author":"de Leon","year":"2026","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/17425255.2024.2373111","article-title":"Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia","volume":"20","author":"de Leon","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ajp.2026.105012_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jagp.2025.08.010","article-title":"A comparative analysis of fatal outcomes in 5,370 geriatric vs. 12,254 non-geriatric adult patients: a clozapine study in VigiBase","volume":"34","author":"de Leon","year":"2026","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ajp.2026.105012_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.ajp.2026.105012_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4088\/JCP.v66n0417","article-title":"Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine","volume":"66","author":"Meltzer","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2026.105012_bib14","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","article-title":"Serious adverse drug events reported to the Food and Drug Administration, 1998\u20132005","volume":"167","author":"Moore","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ajp.2026.105012_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archpsyc.62.3.247","article-title":"The lifetime risk of suicide in schizophrenia: a reexamination","volume":"62","author":"Palmer","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2026.105012_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/JCP.0000000000000490","article-title":"Statistics commentary series: commentary #14\u2013confidence intervals","volume":"36","author":"Streiner","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2026.105012_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104769","article-title":"Monitoring accuracy and balance in pharmacovigilance reporting: the approach of the Asian Journal of Psychiatry","volume":"114","author":"Tandon","year":"2025","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.ajp.2026.105012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","article-title":"The schizophrenia syndrome, circa 2024: what we know and what that tells us about its nature","volume":"264","author":"Tandon","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2026.105012_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001648-199710000-00010","article-title":"Mortality in current and former users of clozapine","volume":"8","author":"Walker","year":"1997","journal-title":"Epidemiology"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201826001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201826001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:28:25Z","timestamp":1779679705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201826001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"alternative-id":["S1876201826001851"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2026.105012","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing your perspective on fatal outcomes in clozapine-treated patients. They do not die of agranulocytosis","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2026.105012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105012"}}